Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Vaskulær endotelial vækstfaktor-terapi ved iskæmisk hjertesygdom.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Kirurgisk behandling ved kvindelig infertilitet

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dopaminergic drugs in the treatment of depression

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Vaccination Against Herpes Zoster

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Surfactant therapy of respiratory distress syndrome

    Research output: Contribution to journalReviewResearchpeer-review

  5. DBCG Kvalitetsdatabase for Brystkræft – resumé af årsrapport 2020

    Research output: Contribution to journalJournal articleCommunication

View graph of relations

Atherosclerosis of coronary arteries can result in a hypoxic state where myocardial cells may become dysfunctional or die. The oxygen sensing transcription factor hypoxia inducible factor 1 responds to low oxygen levels by elevating the production of angiogenic growth factors, such as vascular endothelial growth factor (VEGF). Despite this, endogenous processes and conventional therapies are inefficient in some patients. To stimulate angiogenesis, VEGF has been injected into the myocardium. As stated in this review, this therapy has so far been proven safe and studies are conducted in several countries, including Denmark.

Translated title of the contributionVascular endothelial growth factor therapy in ischaemic heart disease
Original languageDanish
JournalUgeskrift for Laeger
Volume182
Issue number44
ISSN0041-5782
Publication statusPublished - 26 Oct 2020

ID: 62101868